Selecteer een pagina

European Meeting on Molecular Diagnostics (EMMD)

  • Noordwijk, Huis ter Duin, October 14-16, 2015
  • More info

April 27, 2015
> Submission HORIZON2020 proposal

Wednesday 1-3 April 2015
> 2nd Eu-PIC consortium meeting 
Acibadem University Istanbul (TUR)

  • Eu-PIC meeting: April 2, 13:00-18:00
  • Hotel:
  • Organizer:

Final Scientific Programme2nd Eu-PIC Meeting Istanbul

April 2nd 2015, Thursday
Cengiz Yakıcıer, İstanbul, Türkiye
Tanıl Kocagöz, İstanbul, Türkiye
09:15-09:25Opening Remarks 
Candan Hızel, İstabul, Türkiye
09:25-09:45The European Pharmacogenetics Implemetation Consortium: Looking Forward to HORIZON2020 
Ron HN van Schaik, Rotterdam, The Netherlands
09:45-10:05ESPT- The European Research Strategy for Pharmacogenomics and Personalized Medicine 
Gerard Siest, Nancy, France
10:05-10:30Coffee Break
10:30-10:50Keynote Lecture
Pharmacogenomics – Where does it Fit into Personalised Medicine 

Munir Pirmohamed, Liverpool, UK
10:50-11:10Title Pending
Markus Paulmichl, Salzburg, Austria
11:10-11:30Pharmacogenetics and Ethnicity in LatinoAmericans
Adrián Llerena, Badajoz, Spain
11:30-11:50Challenges in the Implementation of an Alzheimer’s Disease Personalized Medicine Strategy 
Howard Bergman, Montreal, Canada
11:50-12:10A High-throughput Real-time PCR Approach to Pharmacogenomics Studies
Peter Jacobs, Brussels, Belgium 
12:10-12:30Pharmacogenetıcs of Drug Induced Liver Injury
Ann Daly, Newcastle, UK
13:30-13:50Pharmacogenetics: What Do Psychiatrists Need to Know
Kemal Arıkan, İstanbul, Türkiye
13:50-14:10RNAi-based personalized therapeutic strategies: Are we there yet?
Şükrü Tüzmen, Famagusta, North-Cyprus
14:10-14:30From a Clinical Point of View: Applications of Pharmacogenetics in Oncology
Haluk Onat, İstanbul, Türkiye
14:30-14:50Evaluation of SNPs in Various Diseases and Drug Response
Mehmet Gündüz, Ankara, Türkiye
14:50-15:10Bioinformatics for Personalized Medicine
Yeşim Aydın Son, Ankara, Türkiye
15:10-15:40Student Presentations
Pharmacogenetic and Pharmacoepigenetic Factors for Irinotekan Drug Response in Colon Cancer Treatment
Duygu Abbasoğlu, Eskişehir, Türkiye
Importance of Multidrug Resistance Gene 1 (MDR 1) in Personalized Cancer Treatment
Arsalan Amirfallah, DVM 
Medical Doctors’ and Students’ Opinion on Euthanasia
Bekir Berker Artukoğlu, İstanbul, Türkiye
15:40-16:00Coffee Break
16:00-16:20Pharmacogenetics of Warfarin: Lessons Learned in Türkiye
Oğuz Öztürk, Istanbul, Türkiye
16:20-16:40Antioxidant Supplementation on Cancer Risk and Concurrent Use of Antioxidants during Cancer Therapy: An Update 
Tomris Özben, Antalya, Türkiye
16:40-17:00Next Generation Multiplexing Analysis, A True Aid for Researchers That Face a Constantly Changing World
Ronald Vos, Ghent, Belgium
17:00-17:20The Role of General Practice in Pharmacogenomics
Gillian Bartlett, Montréal, Canada
17:20-17:40Cell Death-Based Pharmacodynamic Biomarkers for the Prediction of Response to Chemotherapy
Engin Ulukaya, Bursa, Türkiye
17:40-18:00State of Pharmacogenetic Testing in Türkiye
Rıdvan Seçkin Özen, Istanbul, Türkiye
18:00-19:00ESPT Closed Meeting
April 3rd 2015, Friday
09:00-09:20Horizon Scanning: Genomic Medicine?
Maurizio Ferrari, Milan, Italy
09:20-09:40Pharmacogenetic Studies of Ultra-Rapid CYP2C6 metabolizers in Southeast of Türkiye
Şükrü Aynacıoğlu, Gaziantep, Türkiye
09:40-10:00Coffee Break
10:00-10:20Commercialization of Pharmacogenomics / Precision Medicine
Fareed Kureshy, San Diego, Vista, USA
10:20-10:40Pharmacogenomics Approach to 5-Fluorouracil (5-FU)-based Chemotherapy; A Personalized Cancer Management Experience in Dokuz Eylül University, Türkiye
Yasemin Baskın, İzmir, Türkiye
10:40-11:00Drug-Drug Interactions in Cardiovascular Pharmacotherapeutics
Sophie Visvikis-Siest, Nancy, France
11:00-11:20Pharmacovigilance and Adverse Drug Reaction (ADR) Prediction
Semra Şardaş, Istanbul, Türkiye
11:20-11:40Pharmacogenomics and Personalised Medicine of Antidiabetic drugs
Vangelis Manolopoulos, Alexandrouplois, Greece
11:40-12:00Implementation of a clinical research pharmacogenomics program at an academic medical center; Lessons Learned in Italy
Maurizio Simmaco, Roma, Italy
12:00-12:20Closing & Discussion

April 2-3, Istanbul
Dear Colleagues, Dear Friends,

I would like also to take this opportunity to express my heartfelt thanks to each of you, speakers, Eu-PIC members, organizing committee, Scientific/Education committee, organizing secretariat and sponsors for valuable contribution and for agreeing to participate in International Symposium on ADVANCES IN PREDICTIVE & PERSONALIZED MEDICINE” at Acıbadem University in Istanbul. Your valuable contribution and enthusiastic participation made this program a reality. I really believe that your enthusiastic and encouraging participation in this program help accelerate clinical uptake and application of Predictive & Personalized Medicine into mainstream healthcare in this this post-genomics era.

Many thanks to Acıbadem University to have welcomed this program at sumptuous campus in Istanbul. Once again, I would also like to extend my sincere thanks to Prof. Ron HN van Schaik for his very precious and very painstaking help, for his constant encouragement to the state of the art this program. Looking forward to seeing you again in the near future Türkiye.

My kindest personal regards to all of you, On behalf of the organizing committee

Candan HIZEL, PhD; Program Co-Chair

Ron van Schaik, PhD, Eu-PIC PI

(Link to: Pictures 1st Eu-PIC meeting Rotterdam….)

Thursday February 26
1st draft workpackages
Descriptives, deliverables, milestones
Curriculum Vitae’s!

Tuesday 10-11 February 2015
First Eu-PIC consortium meeting 
Erasmus MC Rotterdam (NL)

Monday 27 January 2015
Decision Stage 1 proposals